Coagulation laboratory tests
Reviewer: Jeremy Parsons, M.D. (see Reviewers page)
Revised: 19 June 2012, last major update June 2012
Copyright: (c) 2002-2012, PathologyOutlines.com, Inc.
● Also called anti-alpha2-antiplasmin, plasmin inhibitor
● An uncommon assay usually sent to reference laboratories
● Familial bleeding disorder, after ruling out more common bleeding disorders such as von Willebrand disease
● True alpha2-antiplasmin deficiency is a rare condition (<20 cases)
● Most cases are caused by inhibitors (antibodies)
● Plasma in citrate tube, without epsilon-aminocaproic acid, aprotinin, heparin or other fibrinolysis inhibitors
● Approximately 48-80 mg/dL, lower during first 5 days of life
● Add specific amount of excess plasmin to patientís plasma, measure plasmin that is unbound to antiplasmin in patientís serum by detecting color change spectrophotometrically
● Amount of unbound plasmin detected is inversely proportional to patientís antiplasmin level
Antigenic (immunologic) assay:
● Patientís plasma in placed in the cylindrical well of an agarose gel containing antiplasmin antibody, which defuses into the well and forms an antigen-antibody complex and precipitin ring
● The size of the ring is proportional to the patientís antiplasmin
Acquired causes of decreased antiplasmin:
● Liver disease, thrombolytic therapy, DIC
● J Thromb Haemost 2007;5:812
End of Coagulation > Coagulation laboratory tests > Antiplasmin assay
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).